Akari Therapeutics PLC
NASDAQ:AKTX
Akari Therapeutics PLC
NASDAQ:AKTX
Price:
4.47
USD
-3.87%
Market Closed
Market Cap:
$5.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
US |
|
Colas SA
PAR:RE
|
FR |
|
W
|
World Fuel Services Corp
XBER:WFK
|
US |
|
Granges AB
STO:GRNG
|
SE |
|
Tocca Life Holdings Inc
OTC:TLIF
|
US |
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
Intact Financial Corp
TSX:IFC
|
CA |
|
Nestle SA
F:NESR
|
CH |
|
Green Rise Foods Inc
XTSX:GRF
|
CA |
|
E
|
Easy Holdings Co Ltd
KOSDAQ:035810
|
KR |
|
OceanaGold Corp
TSX:OGC
|
CA |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
G
|
GEN Restaurant Group Inc
NASDAQ:GENK
|
US |
Wall Street
Price Targets
AKTX Price Targets Summary
Akari Therapeutics PLC
Akari Therapeutics PLC
Wall Street analysts forecast AKTX stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
AKTX
is 2.7 USD
with a low forecast of 1.01 USD and a high forecast of 7.35 USD.
Lowest
Price Target
1.01
USD
77% Downside
Average
Price Target
2.7
USD
40% Downside
Highest
Price Target
7.35
USD
64% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AKTX's stock price target?
Price Target
2.7
USD
2.7
USD
According to Wall Street analysts, the average 1-year price target for
AKTX
is 2.7 USD
with a low forecast of 1.01 USD and a high forecast of 7.35 USD.
